• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IRX

INHALERX LIMITED - News & Media

4.00% ! 2.6¢
Market Cap $4.448M  !
Healthcare Medical Devices
Add to My Watchlist

InhaleRx Limited is an Australia-based clinical stage drug development company. The... InhaleRx Limited is an Australia-based clinical stage drug development company. The Company is focused on developing onset, inhaled therapies to address unmet medical needs in pain management and mental health sectors. The Company is focused on the development of IRX211 to treat Breakthrough Cancer Pain (BTcP), and IRX-616a to treat panic disorders. The Company’s operates through single segment that is the development of medical technologies. Its IRX-211 focuses on the management of BTcP with non-opioid, onset inhaled therapy. The Phase I clinical trials for IRX-211 have been completed. Its IRX-616a is an approved inhaled medication for panic disorder, offering a novel treatment avenue. It holds a patent that has been approved, and provisional patents have been lodged. The Company has identified some composition properties in the way the IRX211 drug device has performed and focused on developing resulting novel intellectual property in consultation with its patent attorneys.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

InhaleRX sets up Phase 1 trial for panic disorder inhaler

InhaleRX Ltd has executed a Study Order with iNGENū CRO Pty Ltd to oversee its Phase 1 trial for cannabidiol inhaler IRX-616a

17 Apr 2025 12:37 (AEST)

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain

15 Nov 2024 11:17 (AEDT)

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.

18 Oct 2024 11:47 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.6¢ 		Change
0.001(4.00%) 		Mkt cap ! $4.448M
Open High Low Volume
2.3¢ 2.6¢ 2.3¢ 92.22K

Buyers (Bids)

Vol. Price($)
24741 2.3¢
 

Sellers (Offers)

Price($) Vol.
2.6¢ 95499
Last trade - 13.03pm 12/12/2025 (20 minute delay) ?
IRX (ASX) Chart

Top Stories

EV Resources' antimony processing greenlit ahead of January drilling

EV Resources (ASX:EVR) has seen shares pop +12% as the company sees the processing plant attached to its Mexican antimony mine cleared for operation by technical experts @ a further step, ultimately, towards future production of the critical metal right next door to the North American market (and...
Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer Paul Rennie.
Amid surging prices a new tungsten mine is about to open in South Korea Almonty Industries chief executive Lewis Black updates interested investors on the Sangdong tungsten mine in South Korea.
Neometals brings partner on-board at Ironclad to start open-cut mining, haulage, and toll-milling Neometals is teaming up with BML Ventures for a production joint venture at the Ironclad Gold Deposit in Western Australia.
Listen: HotCopper Wire CY25 Wrapped – Looking back at Invictus, Kaili, DRO, and more In the first half of the HotCopper Wire@s CY25 end-of-year special, Isaac McIntyre and Jonathon Davidson look back over the year that was through the half-dozen biggest stories covered on the podcast and HotCopper.There are a half-dozen that truly stood out, including: DroneShield Invictus En...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.